Rating:- 50
| Issue Open: | Jul 27, 2021 – Jul 29 , 2021 | |||
| Anchor: | Jul 26 , 2021 | |||
| Issue Type: | Book Built Issue | |||
| Face Value: | Rs. 2 Per Equity Share | |||
| Equity Shares After Issue | 12,25,27,172 Equity Share | |||
| Market Cap Issue Price | Rs. 8,822.96 Cr. | |||
| Issue Size: | Fresh Rs. 1060.00 Cr OFS 63,00,000 Equity Share | |||
| Issue Size: | Rs. 1497.85 - 1513.60 Cr | |||
| QIB: | 50% | |||
| NII: | 15% | |||
| Retail: | 35% | |||
| Issue Price: | Rs. 695 - 720 Per Equity Share | |||
| Market Lot: | 20 (14,400) | |||
| Listing At: | BSE , NSE | |||
| Registrar: | karisma.kfintech.com | |||
| Company Website: | www.glenmarklifesciences.com | |||
| Retail Applications For One Time: | 3,67,889 | |||
| Grey Market: | 1. Premium | 91 - 130 |
||
| 2. Kostak Price | 350 |
|||
| 3. Sub. 2 Kostak | 1600 - 2000 |
|||
| Timetabel: | Allotment | Aug 3, 2021 | ||
| Unblocking | Aug 4, 2021 | |||
| Listing | Aug 6, 2021 | |||
| Last Day Subscription Detail NSE + BSE | ||||
| QIB: | 37.30 |
|||
| NII: | 125.62 |
|||
| Retail: | 15 |
|||
| Total: | 45.08 |
|||
| Applications Approx : | 39,50,392 |
|||
| No. of Applicant wise: | 10.74x |
|||

No comments:
Post a Comment